Human Neuropeptide Y
From PeptidePlaza, the free peptide reference · Entry #1006 · Nootropic · Sources fetched 2026-09-10 · Editorial standards
Human Neuropeptide Y (also known as Neuropeptide Y (human,rat), YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY) is a nootropic research peptide. Human Neuropeptide Y is an investigational peptide that acts as a ligand for neuropeptide Y receptors.
Human Neuropeptide Y is a peptide under investigation for its role in biological systems. It functions as a ligand for neuropeptide Y receptors, influencing various physiological processes. Research has explored its structural characteristics, including its crystal and solution structures, and its interaction with specific receptor subtypes. Studies have also investigated the C-terminal motif of the human neuropeptide Y4 receptor in relation to internalization and arrestin recruitment, as well as the inhibition of neuropeptide Y-evoked vasoconstriction by antisense oligodeoxynucleotides targeting the Y1 receptor.
1 Chemical and physical properties
| Molar mass | 4272 g/mol |
|---|---|
| Purity (typical) | Not independently verified |
| Storage | −20 °C, lyophilised powder, desiccated |
| Solubility | Sterile water / bacteriostatic water |
2 Research studies (8)
- N-(4-[(18)F]Fluoro-benzoyl)-N'-{2-[5-(4-fluoro-benzyl)-1-(4-methoxy-benzyl)-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-ylamino]-ethyl}-guanidine
(2004) · Review - Crystal structures of human neuropeptide Y (NPY) and peptide YY (PYY)
Neuropeptides (2022) - Solution structure of human neuropeptide Y
Journal of biomolecular NMR (1996) - Human neuropeptide Y Y1 receptor antisense oligodeoxynucleotide specifically inhibits neuropeptide Y-evoked vasoconstriction
European journal of pharmacology (1993) - C-terminal motif of human neuropeptide Y(4) receptor determines internalization and arrestin recruitment
Cellular signalling (2017) - Cell-Free Expression and Photo-Crosslinking of the Human Neuropeptide Y(2) Receptor
Frontiers in pharmacology (2019) - Micellar nanomedicine of human neuropeptide Y
Nanomedicine : nanotechnology, biology, and medicine (2011) - Expression of the human neuropeptide Y gene
The Journal of biological chemistry (1990)
3 Safety and risk profile
3.1 Regulatory status
Human Neuropeptide Y is currently classified as Investigational. It has no approved human indication in the United States; availability elsewhere does not imply demonstrated safety or efficacy.
4 Frequently asked questions
- What is Human Neuropeptide Y?
- Human Neuropeptide Y is an investigational peptide that serves as a ligand for neuropeptide Y receptors. It is being studied for its biological functions and interactions within the body.
- How does Human Neuropeptide Y work?
- Human Neuropeptide Y works by binding to neuropeptide Y receptors. This interaction can influence various cellular processes, including vasoconstriction and receptor internalization, depending on the specific receptor subtype involved.
- What is the regulatory status of Human Neuropeptide Y?
- Human Neuropeptide Y is currently in an investigational stage. This means it is undergoing research and development to understand its properties and potential applications.
- What has been studied about Human Neuropeptide Y?
- Studies on Human Neuropeptide Y have focused on its crystal and solution structures, its interaction with neuropeptide Y receptor subtypes, and the mechanisms of receptor internalization and arrestin recruitment. Research also includes investigations into its effects on vasoconstriction.
5 References
- Human Neuropeptide Y — compound summary PubChem. View source
- Human Neuropeptide Y — molecule record ChEMBL. View source
- Human Neuropeptide Y — published literature (148 records) PubMed. View source
Related compounds
Entries that share a target, a mechanism, or a research area with Human Neuropeptide Y.
Also nootropic
Substance P, also known as Neurokinin P, is an endogenous human peptide and a member of the tachykinin family.
Also nootropic
Vasoactive Intestinal Peptide (VIP) is a neuropeptide that activates VIP receptor 1 (VPR1) and VIP receptor 2 (VPR2), which are G protein-coupled receptors.
Also nootropic
A nine-amino-acid neuropeptide hormone best known for childbirth and lactation, now studied extensively for social bonding, stress regulation, wound healing, and metabolic effects via intranasal delivery.
Also nootropic
A cyclic heptapeptide melanocortin receptor agonist and active metabolite of Melanotan II. Unlike peripheral vasodilators, PT-141 acts centrally via the CNS to modulate arousal and food intake pathways.
Also nootropic
A potent cyclic analog of α-MSH that activates melanocortin receptors broadly. Studied for UV-independent melanogenesis, appetite suppression, and as the parent compound of PT-141 (Bremelanotide).
Also nootropic
Eptifibatide is an integrin alpha-IIb/beta-3 inhibitor used to decrease the rate of death or myocardial infarction in patients with acute coronary syndrome and those undergoing percutaneous coronary intervention.